The Amniocentesis Needle market can be segmented based on product type into 100 to 150 mm, smaller than 100 mm, and larger than 150 mm. The 100 to 150 mm segment is expected to dominate the market in terms of size and share due to its widespread usage in amniocentesis procedures. On the other hand, the smaller than 100 mm segment is expected to witness significant growth in the forecast period, driven by the increasing adoption of minimally invasive procedures. The larger than 150 mm segment is likely to show steady growth owing to its specialized use in specific cases.
Procedure:
Under the procedure segment, the market can be categorized into amniocentesis, amnioreduction, amnioinfusion, and cordocentesis. Amniocentesis is projected to hold the largest market share as it is the most commonly performed prenatal diagnostic procedure. The amnioreduction and amnioinfusion segments are expected to witness moderate growth due to their use in managing complications during pregnancy. Cordocentesis, although a niche procedure, is anticipated to show steady growth as it is performed in high-risk pregnancies.
End-use:
The end-use segment of the Amniocentesis Needle market comprises hospitals, diagnostics centers, and clinics. Hospitals are expected to be the major end-users of amniocentesis needles due to their advanced infrastructure and the availability of skilled healthcare professionals for performing the procedure. Diagnostics centers are likely to witness significant growth as they offer specialized prenatal diagnostic services. Clinics, on the other hand, are projected to show steady growth, catering to the increasing demand for prenatal care services in local communities.